|
π
|
Fatty acid-mediated signaling as a target for developing type 1 diabetes therapies
9 auth.
Ivo DΓaz Ludovico,
Soumyadeep Sarkar,
Emily C. Elliott,
S. Virtanen,
I. Erlund,
Sasanka Ramanadham,
...
R. Mirmira,
Thomas O. Metz,
E. Nakayasu
|
2 |
2023 |
2
π
|
|
π
|
Regulation of Ξ²-cell death by ADP-ribosylhydrolase ARH3 via lipid signaling in insulitis
25 auth.
Soumyadeep Sarkar,
Cailin S Deiter,
J. Kyle,
Michelle A. Guney,
Dylan Sarbaugh,
Ruichuan Yin,
Xiangtang Li,
Yi Cui,
M. Ramos-RodrΓguez,
C. Nicora,
Farooq Syed,
J. Juan-Mateu,
Charanya Muralidharan,
Lorenzo Pasquali,
C. Evans-Molina,
...
D. Eizirik,
B. Webb-Robertson,
Kristin E. Burnum-Johnson,
G. Orr,
Julia Laskin,
Thomas O. Metz,
R. Mirmira,
Lori Sussel,
C. Ansong,
Ernesto S. Nakayasu
|
2 |
2024 |
2
π
|
|
π
|
Decrease in multiple complement proteins associated with development of islet autoimmunity and type 1 diabetes
15 auth.
B. Webb-Robertson,
E. Nakayasu,
Fran Dong,
Kathy C. Waugh,
Javier E. Flores,
LisaΒ M. Bramer,
Athena A. Schepmoes,
Yuqian Gao,
T. Fillmore,
S. Onengut-Gumuscu,
...
Ashley Frazer-Abel,
S. S. Rich,
V. M. Holers,
Thomas O. Metz,
Marian J Rewers
|
1 |
2023 |
1
π
|
